| Original language | English |
|---|---|
| Journal | OncoImmunology |
| Volume | 5 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2016 |
Cite this
}
Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells. / van Dodewaard-de Jong, Joyce M.; Santegoets, Saskia J. A. M.; van de Ven, Peter M.; Versluis, Jurjen; Verheul, Henk M. W.; de Gruijl, Tanja D.; Gerritsen, Winald R.; van den Eertwegh, Alfons J. M.
In: OncoImmunology, Vol. 5, No. 4, 2016.Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Improved efficacy of mitoxantrone in patients with castration-resistant prostate cancer after vaccination with GM-CSF-transduced allogeneic prostate cancer cells
AU - van Dodewaard-de Jong, Joyce M.
AU - Santegoets, Saskia J. A. M.
AU - van de Ven, Peter M.
AU - Versluis, Jurjen
AU - Verheul, Henk M. W.
AU - de Gruijl, Tanja D.
AU - Gerritsen, Winald R.
AU - van den Eertwegh, Alfons J. M.
PY - 2016
Y1 - 2016
KW - Cancer vaccines
KW - chemotherapy
KW - docetaxel
KW - GVAX
KW - immunotherapy
KW - mitoxantrone
KW - prostate cancer
U2 - 10.1080/2162402X.2015.1105431
DO - 10.1080/2162402X.2015.1105431
M3 - Article
VL - 5
JO - OncoImmunology
JF - OncoImmunology
SN - 2162-4011
IS - 4
ER -